197 related articles for article (PubMed ID: 33686103)
1. Association between the C-reactive protein/albumin ratio and prognosis in patients with oral squamous cell carcinoma.
Yamagata K; Fukuzawa S; Ishibashi-Kanno N; Uchida F; Bukawa H
Sci Rep; 2021 Mar; 11(1):5446. PubMed ID: 33686103
[TBL] [Abstract][Full Text] [Related]
2. Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.
Tanoue K; Tamura S; Kusaba H; Shinohara Y; Ito M; Tsuchihashi K; Shirakawa T; Otsuka T; Ohmura H; Isobe T; Ariyama H; Koreishi S; Matsushita Y; Shimokawa H; Tanaka R; Mitsugi K; Akashi K; Baba E
Sci Rep; 2021 Feb; 11(1):2741. PubMed ID: 33531609
[TBL] [Abstract][Full Text] [Related]
3. Preoperative high c-reactive protein/albumin ratio is a poor prognostic factor of oral squamous cell carcinoma.
Wang Q; Song X; Zhao Y; He Q; Shi M; Xu P; Ni S; Chen Y; Lin J; Zhang L
Future Oncol; 2019 Jul; 15(19):2277-2286. PubMed ID: 31237166
[No Abstract] [Full Text] [Related]
4. A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma.
Fang KH; Lai CH; Hsu CM; Huang E; Tsai MS; Chang GH; Lee YC; Tsai YT
PeerJ; 2020; 8():e9361. PubMed ID: 32587804
[TBL] [Abstract][Full Text] [Related]
5. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
8. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
9. The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer.
Zhang F; Ying L; Jin J; Chen K; Zhang N; Wu J; Zhang Y; Su D
Oncotarget; 2017 Jan; 8(5):8835-8842. PubMed ID: 27823974
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
12. High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma.
Jung J; Lee H; Heo JY; Chang MH; Lee E; Park WS; Park JH; Eom HS
Sci Rep; 2021 Jan; 11(1):2674. PubMed ID: 33514832
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.
Grimm M; Lazariotou M
Med Oncol; 2012 Sep; 29(3):1435-47. PubMed ID: 21853343
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer.
Ishibashi Y; Tsujimoto H; Hiraki S; Kumano I; Yaguchi Y; Horiguchi H; Nomura S; Ito N; Shinto E; Aosasa S; Yamamoto J; Ueno H
Ann Surg Oncol; 2018 Oct; 25(11):3288-3299. PubMed ID: 30019304
[TBL] [Abstract][Full Text] [Related]
16. [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].
Chen YY; Zhang JH; Zhang W; Yang ZK; Luo RC; Kang SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):622-627. PubMed ID: 28539284
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan.
Tsujino T; Komura K; Hashimoto T; Muraoka R; Satake N; Matsunaga T; Tsutsumi T; Yoshikawa Y; Takai T; Minami K; Uehara H; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Ohno Y; Azuma H
Urol Oncol; 2019 Nov; 37(11):812.e1-812.e8. PubMed ID: 31053528
[TBL] [Abstract][Full Text] [Related]
19. The Value of the C-Reactive Protein-to-Albumin Ratio is Useful for Predicting Survival of Patients with Child-Pugh Class A Undergoing Liver Resection for Hepatocellular Carcinoma.
Shimizu T; Ishizuka M; Suzuki T; Tanaka G; Shiraki T; Sakuraoka Y; Matsumoto T; Kato M; Aoki T; Kubota K
World J Surg; 2018 Jul; 42(7):2218-2226. PubMed ID: 29288307
[TBL] [Abstract][Full Text] [Related]
20. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
